NCT03132415

Get Connected Efficacy Trial

Completed NA Results posted Last updated 18 March 2024

What this trial tests

NA trial testing Get Connected in HIV Infections in 285 participants. Completed in 30 June 2022.

Timeline

1 November 2017

Primary endpoint
15 December 2021

30 June 2022

Quick facts

Lead sponsor	University of Pennsylvania
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	285
Start date	1 November 2017
Primary completion	15 December 2021
Estimated completion	30 June 2022
Sites	3 locations across United States

Drugs / interventions tested

• Get Connected
• HIV Test Locator

Conditions studied

• HIV Infections — all drugs for HIV Infections →

Sponsor

University of Pennsylvania

Who can join

Adults 15 to 24, male only, with HIV Infections. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Percent of Participants Reporting Changes in Their HIV Testing Behavior Using Self-report Questionnaires Primary · 12 month

The investigators will estimate the proportion of participants who test at least twice for HIV over a 12-month period by intervention group.

Group	Value	95% CI
Get Connected	53
HIV Test Locator	54

Percent of Participants Reporting Changes in PrEP Uptake Using Self-report Questionnaires Secondary · 12 month

The investigators will test the proportion of the sample that begins PrEP during the 12-month follow-ups.

Group	Value	95% CI
Get Connected	38
HIV Test Locator	36

Percent of Participants Reporting Changes in Their STI Testing Behavior Using Self-report Questionnaires Secondary · 12 month

The investigators will estimate the proportion of participants who test for STIs at least once over the trial period.

Group	Value	95% CI
Get Connected	73
HIV Test Locator	75

Sponsor's own description

Get Connected (GC) is an online brief intervention that employs individual and systems-level tailoring technology to reduce barriers to HIV prevention care (e.g., HIV/STI testing, PrEP) for YMSM. The deployment of GC through a mobile-friendly WebApp seeks to optimize online interventions' acceptability, accessibility, availability, long-term affordability among youth. The investigators will enroll self-reported HIV-negative or sero-status unaware, sexually active YMSM (ages 15-24) across three cities and randomize them into the GC intervention condition or to an attention-control condition. Assessments will be collected at 30 days and at 3, 6, 9 and 12 month follow-up.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

1. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020.
   Tanner MR, Miele P, Carter W, Valentine SS, et al · · 2020 · cited 63× · PMID 32324724 · DOI 10.15585/mmwr.rr6903a1
2. University of North Carolina/Emory Center for Innovative Technology (iTech) for Addressing the HIV Epidemic Among Adolescents and Young Adults in the United States: Protocol and Rationale for Center Development.
   Hightow-Weidman LB, Muessig K, Rosenberg E, Sanchez T, et al · · 2018 · cited 40× · PMID 30076126 · DOI 10.2196/10365
3. A Multilevel Tailored Web App-Based Intervention for Linking Young Men Who Have Sex With Men to Quality Care (Get Connected): Protocol for a Randomized Controlled Trial.
   Bauermeister JA, Golinkoff JM, Horvath KJ, Hightow-Weidman LB, et al · · 2018 · cited 38× · PMID 30072358 · DOI 10.2196/10444
4. Enhancing routine HIV and STI testing among young men who have sex with men: primary outcomes of the get connected clinical randomized trial (ATN 139).
   Bauermeister JA, Horvath KJ, Lin WY, Golinkoff JM, et al · · 2024 · PMID 38632603 · DOI 10.1186/s12889-024-18522-w